BTSG vs. EW: BrightSpring Health Services vs. Edwards Lifesciences Stock Comparison

Company Profile

BrightSpring Health Services (BTSG) and Edwards Lifesciences (EW) both fall under the Health Care Equipment & Services industry group, but BTSG is classified in Health Care Providers & Services while EW is classified in Health Care Equipment & Supplies.

Edwards Lifesciences (EW) carries decades of public-market history since March 27, 2000, while BrightSpring Health Services (BTSG) listed on January 26, 2024 — long-window comparisons have far more historical data on the EW side.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

BrightSpring Health Services (BTSG) at 15.54% sits in the top ROE quartile, while Edwards Lifesciences (EW) at 9.33% is closer to the peer norm — stronger capital efficiency for BTSG.

Edwards Lifesciences (EW) at 15.30% retains a top-quartile share of revenue as profit, ahead of BrightSpring Health Services (BTSG) at 2.69%, which keeps about the industry-typical share.

Edwards Lifesciences (EW) at 30.15% operates in the top operating margin quartile, ahead of BrightSpring Health Services (BTSG) at 3.81%, which runs around its industry’s norm.

Profitability Metrics

Growth

BrightSpring Health Services (BTSG) at 28.18% sits in the top revenue growth quartile, while Edwards Lifesciences (EW) at 11.55% is closer to the peer norm — faster top-line expansion for BTSG.

Only one side can be read here: Edwards Lifesciences (EW) reports EPS growth of -73.74%, ranked against its industry; BrightSpring Health Services (BTSG) has no EPS growth figure this period.

Growth Metrics

Financial Strength

BrightSpring Health Services (BTSG) at 1.62 keeps current ratio within its industry’s typical mid-range, while Edwards Lifesciences (EW) at 4.60 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

Edwards Lifesciences (EW) at 0.06 keeps leverage in the lower quartile, while BrightSpring Health Services (BTSG) at 1.09 sits in the higher-leverage quartile.

Financial Strength Metrics

Dividends

Neither BrightSpring Health Services (BTSG) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither BrightSpring Health Services (BTSG) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

BrightSpring Health Services (BTSG) at 47.62 is near its industry’s usual P/E ratio, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — EW needs stronger growth or earnings quality to justify the premium.

BrightSpring Health Services (BTSG) at 0.88 looks cheap on sales in the lower P/S ratio quartile, while Edwards Lifesciences (EW) at 8.80 looks rich in the upper quartile — a clear gap in price per dollar of revenue.

Edwards Lifesciences (EW) at 5.41 is valued about in line with its industry on P/B ratio, while BrightSpring Health Services (BTSG) at 6.39 carries an above-peer premium to book — BTSG is pricier on assets.

Valuation Metrics